Recruiting studies: Cutaneous Lupus Erythematosus Cle

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
Phase 3 · 13 location(s) · EMD Serono Research & Development Institute, Inc. · NCT07355218 A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
Phase 3 · 13 location(s) · EMD Serono Research & Development Institute, Inc. · NCT07332481 Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease
Phase 1 · 2 location(s) · Seismic Therapeutic AU Pty Ltd · NCT07455578 A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants
Phase 1/Phase 2 · 7 location(s) · DualityBio Inc. · NCT06625671 Cutaneous Lupus Registry
Phase N/A · 1 location(s) · University of Texas Southwestern Medical Center · NCT01266915 A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the
Phase 2 · 32 location(s) · Ventus Therapeutics U.S., Inc. · NCT07260877 Research Accelerated by You Lupus Registry
Phase N/A · 1 location(s) · Lupus Foundation of America · NCT06927219 Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus
Phase N/A · 2 location(s) · University of Pennsylvania · NCT01510067 Evaluate the Efficacy and Safety of ICP-488 in Subjects With Cutaneous Lupus Erythematosus (CLE) Double-blind Study
Phase 2 · 27 location(s) · Beijing InnoCare Pharma Tech Co., Ltd. · NCT07440537

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.